Skip to content

Clinical trials

Coronary Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Clear all

1,496 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200016
200120
200219
200351
200439
200542
200657
200758
200854
200956
201069
201145
201281
201353
201445
201553
201647
201758
201833
201934
202041
202160
202239
202340
202447
202547
202631

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed984
Unknown status256
Recruiting77
Terminated47
Active, not recruiting46
Not yet recruiting40
Withdrawn33
Enrolling by invitation9
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)194
Abbott Medical Devices32
Deutsches Herzzentrum Muenchen23
China National Center for Cardiovascular Diseases21
AstraZeneca16
Beijing Anzhen Hospital13
CardioDx12
Organon and Co12
China Academy of Chinese Medical Sciences11
University of Edinburgh11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease1,496
Cardiovascular Diseases472
Heart Diseases373
Coronary Artery Disease304
Myocardial Ischemia208
Myocardial Infarction161
Atherosclerosis119
Diabetes Mellitus105
Hypertension99
Stroke97

Trials

Showing 51 to 75 of 1,496. Each trial links to its page on Pharma Observatory.

1,396 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.